Eye Infections Market Report 2026

Eye Infections Market Overview

• Eye Infections market size has reached to $7.93 billion in 2025 • Expected to grow to $10.24 billion in 2030 at a compound annual growth rate (CAGR) of 5.2% • Growth Driver: Rising Prevalence Of Eye-Related Disorders To Drive Growth In The Market • Market Trend: Advancing Eye Infection Therapies The Role Of Photodynamic Treatment And Strategic Collaborations • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Eye Infections Market?

Eye infections are conditions where harmful microorganisms, such as bacteria, viruses, or fungi, infect parts of the eye, leading to inflammation, discomfort, and sometimes vision impairment. These infections can affect the eyelid, cornea, conjunctiva, or deeper eye structures. Symptoms commonly include redness, pain, discharge, swelling, and sensitivity to light. Eye infections may be contagious and require prompt medical treatment to prevent complications. The main indications of eye infections are conjunctivitis, keratitis, endophthalmitis, blepharitis, stye, uveitis, cellulitis, and ocular herpes. Conjunctivitis, commonly known as pink eye, is the inflammation or infection of the conjunctiva, which is the thin, transparent tissue that lines the inner surface of the eyelids and covers the white part of the eyeball. Treatment options typically involve corticosteroids, quinolone antibiotics, macrolide antibiotics, tetracycline antibiotics, and polyene antifungals. These medications are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Eye Infections Market Growth Forecast?

The eye infections market size is expected to see strong growth in the next few years. It will grow to $10.24 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to development of novel antimicrobial eye drugs, increasing aging population, rising digital eye strain cases, improved access to ophthalmic care, growth of online pharmacies. Major trends in the forecast period include rising prevalence of bacterial and viral eye infections, increased use of prescription ophthalmic drugs, growing awareness of early diagnosis and treatment, expansion of online and retail pharmacy channels, development of broad-spectrum ophthalmic therapies.

Global Eye Infections Market Segmentation

1) By Indications: Conjunctivitis, Keratitis, Endophthalmitis, Blepharitis, Stye, Uveitis, Cellulitis, Ocular Herpes 2) By Drug Type: Corticosteroids, Quinolone Antibiotics, Macrolide Antibiotics, Tetracycline Antibiotics, Polyene Antifungals 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Conjunctivitis: Bacterial Conjunctivitis, Viral Conjunctivitis, Allergic Conjunctivitis 2) By Keratitis: Bacterial Keratitis, Viral Keratitis, Fungal Keratitis, Acanthamoeba Keratitis 3) By Endophthalmitis: Post-surgical Endophthalmitis, Post-traumatic Endophthalmitis, Endogenous Endophthalmitis 4) By Blepharitis: Anterior Blepharitis, Posterior Blepharitis 5) By Stye: Internal Stye, External Stye 6) By Uveitis: Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, Panuveitis 7) By Cellulitis: Periorbital Cellulitis, Orbital Cellulitis 8) By Ocular Herpes: Herpes Simplex Keratitis, Herpes Simplex Conjunctivitis

What Is The Driver Of The Eye Infections Market?

The increasing incidence and prevalence of eye-related disorders is expected to drive the eye infections market. Eye-related disorders refer to a range of conditions affecting the eyes, including diseases such as glaucoma, cataracts, macular degeneration, and refractive errors such as myopia and hyperopia. The increase in the number of patients with eye-related disorders is due to factors such as aging populations, lifestyle changes, environmental factors, and lack in diagnostic capabilities leading to delay in problem detection. Eye infections can contribute to the development or worsening of eye-related disorders by causing inflammation, tissue damage, and impairing the eye's natural defenses, ultimately leading to complications such as vision loss or chronic conditions. For instance, in October 2024, according to the World Health Organization, a Switzerland-based health authority, in 2023, 130,746 individuals underwent surgical treatment for advanced trachoma, and 32.9 million received antibiotics, with a global coverage of 29%. Therefore, the increasing incidence and prevalence of eye-related disorders will drive the eye infections industry going forward.

Key Players In The Global Eye Infections Market

Major companies operating in the eye infections market are Pfizer Inc, F. Hoffmann-La Roche AG, Merck And Co Inc, AbbVie Inc., Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals Inc, Alcon Laboratories Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Santen Pharmaceuticals Co Ltd, Rohto Pharmaceutical Co Ltd, Alembic Pharmaceuticals Limited, Novaliq GmbH, Eyevance Pharmaceuticals LLC, Ocular Therapeutix, I-Med Pharma Inc., EyeGate Pharmaceuticals Inc

Global Eye Infections Market Trends and Insights

Major companies operating in the eye infections market are focusing on developing innovative therapies such as photodynamic therapy to enhance treatment efficacy and reduce side effects. Photodynamic therapy is a treatment that involves using a light-sensitive drug activated by specific light wavelengths to target and destroy abnormal or infected cells. For instance, in December 2024, VisiRose Inc., a US-based clinical-stage biotechnology company, partnered with Provectus Biopharmaceuticals Inc., a US-based pharmaceutical company, and Bascom Palmer Eye Institute, a US-based health center, to launch Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT), a groundbreaking, non-invasive investigational treatment for infectious keratitis and other serious eye infections. The RB PDAT presents a promising solution to the escalating global issue of antimicrobial resistance (AMR), offering a broad-spectrum ocular treatment. This therapy is designed to be safe, effective, and cost-efficient, addressing the urgent need for innovative treatments in this area.

What Are Latest Mergers And Acquisitions In The Eye Infections Market?

In July 2024, Merck And Co., Inc., a US-based science and technology company that develops medicines, vaccines, and other health solutions, acquired EyeBio for $3 billion. With this acquisition, Merck aims to expand its ophthalmology pipeline and develop innovative treatments for retinal diseases. Eyebiotech Limited is a UK-based biotechnology company that developed therapies for eye diseases.

Regional Outlook

North America was the largest region in the eye infections market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Eye Infections Market?

The eye infections market consists of sales of antibiotics, antifungal drugs, antiviral drugs, steroid eye drops, and surgical interventions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Eye Infections Market Report 2026?

The eye infections market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the eye infections industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.